COMMUNIQUÉS West-GlobeNewswire

Retrophin Reports Third Quarter 2018 Financial Results
01/11/2018
Pivotal programs enrolling towards first data readout in 2019 Phase 2 study of CNSA-001 in PKU underway; top-line results expected in first half 2019 Completed offering of $276 million convertible senior notes due 2025 [...]
Adamas Reports Third Quarter 2018 Financial Results
01/11/2018
GOCOVRI™ (amantadine) extended release capsules sales increased to $10.6 million for the third quarter, with ~4,740 fulfilled prescriptions EMERYVILLE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, [...]
Align Technology SVP Chris Puco to Depart in March 2019
01/11/2018
SAN JOSE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today announced that Christopher C. Puco, senior vice president and managing director of the Americas region, has decided to [...]
IntelGenx to Report Third Quarter 2018 Financial Results on November 8, 2018 – Conference Call to Follow
01/11/2018
SAINT LAURENT, Quebec, Nov. 01, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its third quarter 2018 financial results after market close on [...]
Cytokinetics, Inc. Reports Third Quarter 2018 Financial Results
01/11/2018
METEORIC-HF Advancing to Trial Initiation FORTITUDE-ALS on Track to Complete Enrollment by Year End Phase 1 Clinical Studies of CK-274 and AMG 594 To Start in Q4 SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE [...]
Weekend Unlimited: Emerging Cannabis Lifestyle Brand -- CFN Media
01/11/2018
SEATTLE, Nov. 01, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
Holding(s) in Company
01/11/2018
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]
Director/PDMR Shareholding
01/11/2018
Director/PDMR Shareholding November 1, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]
The Villages Health and elminda joint Study Receives Erickson Foundation Award for Excellence in Aging Research at 2018 APHA Annual Meeting
01/11/2018
HERZLIYA, Israel and THE VILLAGES, Fla., Nov. 01, 2018 (GLOBE NEWSWIRE) -- elminda Ltd., an emerging medical technology company dedicated to paving a path to better brain health by integrating big-data repositories, [...]
GPS Ankle Bracelet Private Rental Program Open to Applicants in Canada
01/11/2018
SafeTracks GPS Canada Inc. now offers an alternative to incarceration RED DEER, Alberta, Nov. 01, 2018 (GLOBE NEWSWIRE) -- It is no secret that Canadian remands and prisons are overcrowded. There is an opportunity for [...]
Apellis Pharmaceuticals Announces Poster Presentations at the American Society of Hematology Annual Meeting
01/11/2018
CRESTWOOD, Ky. and WALTHAM, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
I-MED Pharma Partners with Iogen Oy to Introduce I-DROP®, I-LID ’N LASH®, I-RELIEF™ Therapeutic Eye Mask and the I-PEN® Osmolarity System to the Finnish Market
01/11/2018
MONTREAL, Nov. 01, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive distribution agreement with Iogen Oy [...]
ASLAN Pharmaceuticals to Present New Data on ASLAN003 at American Society of Hematology Annual Meeting
01/11/2018
SINGAPORE, Nov. 01, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]
The Alliance for Regenerative Medicine Releases Q3 2018 Data Report, Highlighting Sector Trends and Metrics
01/11/2018
WASHINGTON, DC , Nov. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly data report, offering an in-depth look at cell therapy, gene [...]
NewLink Genetics Announces Oral Presentation at the 2018 American Society of Hematology (ASH) Annual Meeting
01/11/2018
AMES, Iowa, Nov. 01, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that an abstract with data pertaining to the use of the Company's investigational immuno-oncology molecule, [...]
TG Therapeutics, Inc. Announces Triple Therapy Data Presentations at the Upcoming 60th American Society of Hematology Annual Meeting and Exposition
01/11/2018
Investor and Analyst Event to be Held on Sunday December 2, 2018 at 7:30 PM PT at the Marriot Gaslamp San Diego with Presentations by Leading Clinical Investigators NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- TG [...]
Bavarian Nordic Announces Initiation of Phase 2 Trial of BN-Brachyury for the Treatment of Chordoma
01/11/2018
First dose has been administered in the multiple-center study BN-Brachyury for the treatment of chordoma received FDA Orphan Drug Designation in May 2018 COPENHAGEN, Denmark, November 1, 2018 - Bavarian Nordic A/S (OMX [...]
Aptose to Present New CG-806 Data at the 2018 ASH Annual Meeting
01/11/2018
SAN DIEGO and TORONTO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the [...]
Merit Medical to Present at Four Conferences in November
01/11/2018
SOUTH JORDAN, Utah, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]

Pages